News

With the EPIICAL project being a hive of activity over the last year, we have collected a selection of contributions, stories and articles to bring you the very first edition…

Today marks the official launch of the restyled Penta logo and new-look website!

We are delighted to announce the selection of the c4c consortium’s first portfolio of pan-European paediatric studies aimed at advancing the understanding of high priority medicines commonly used in babies,

On April 5th-7th Padova (Italy) hosted the Global Health Festival. The aim of the festival was to investigate scientific progress and explore technological advances and policies that let the right to…

We are pleased to announce the launch of the brand new REACH project website!

The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitrodiagnostic companies who join forces…

The c4c consortium has issued a call for tender for subcontracting a specialised business school or company that can assist in the development of a sustainable business model for a pan-European paediatric clinical trials…

The first edition of the Global Health Festival (‘Festival della Salute Globale’) is to take place in Padova, Italy on 5th-7thApril 2019. In partnership with Comune di Padova, Università degli…

The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington. At this year's event, EPIICAL team member Sara Dominguez…

The ODYSSEY project team members Pauline Bollen and Anna Turkova successfully presented a poster with the results of an important pharmacokinetic sub-study on the use of adult Dolutegravir 50mg tablets in children…

The European Medicines Agency (EMA) has recently published a booklet covering the process undertaken for medicines for human use and which are authorised through the EU centralised procedure. With a user-friendly…

Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments…

Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event in…

Penta project manager Davide Bilardi, together with other NeoObs project partners, recently visited the neonatal units of the Santa Casa Hospital in São Paolo and the Clinical Research Unit of…

Last week saw the EMPIRICAL project get off to a great start with the Kick-off Meeting held in Lusaka, Zambia on 19th-20th February. Various items were discussed on the agenda…

Today St. Petersburg welcomes over 40 partners for the REACH Kick-off Meeting (11th-12th February). REACH is a H2020 project, approved and funded by the European Commission, and coordinated by Penta.…

The countdown has begun to Rare Disease Day 2019 on 28th February. People around the world are joining the global movement for rare diseases by taking part in the #ShowYourRare…

The many challenges of developing drugs appropriately formulated for children are compounded by a series of market factors that make these efforts costly and complex, discouraging drug manufacturers – especially…